COVID 19

PharmAust shares soar following promising COVID-19 treatment results

Finfeed Archived Jun 04, 2020

PharmAust's (ASX:PAA) demonstrates both infectivity and replication of SARS-CoV-2 virus particles can be suppressed in cell cultures.

Could a NASDAQ Listing Put MYQ on the US Health & Fitness Map?

Next Investors Jun 01, 2020

Software as a service (SaaS) solution provider MyFiziq Limited (ASX: MYQ) is set for a secondary listing on the NASDAQ Capital Market.

Managing Employees 'Back to Work' – what processes and habits to keep

Finfeed Archived May 27, 2020

What are the 5 behaviours employers and employees need to adopt as we look at moving back into office work mode, or combinations of work from home and office work.

Podcast: How business can navigate its way through the COVID-19 pandemic and beyond

Finfeed Archived May 20, 2020

Economic recovery in the post COVID-19 landscape is going to take an enormous effort, with businesses, governments, employers and employees all having to work together to make it happen. Yemi Penn is here to tell us how we can achieve a smooth transition back to the new normal.

Noxopharm receives FDA green light to progress towards Veyonda® trial

Finfeed Archived May 19, 2020

Noxopharm has received advice from the FDA to submit Veyonda® for clinical trial in patients infected with COVID-19

Is Zoom one of the new essential services?

Finfeed Archived May 14, 2020

As homemade bread, Zoom (NASDAQ: ZM) and online groceries form the new essentials of COVID life, a question emerges for the people who plan and build our cities: are the COVID-19 essentials a temporary disruption to our lives and businesses? Is this a blip or should we relook at the value of the essential services that sustain us in a time of crisis in a new light?

Will a second wave of Covid-19 send stock markets into a spin?

Finfeed Archived May 13, 2020

The sharp downturn in the ASX could be the start of a much steeper decline if a lead is taken from US markets, particularly regarding the potential for a second wave of COVID-19.

Plenty of run left in Genetic Signatures

Finfeed Archived May 11, 2020

There has been continual strong news flow from the Genetic Signature Ltd (ASX: GSS), as it received CE-IVD registration for its SARS-CoV-2 Detection Kit, as well as notification from the Therapeutic Goods Administration (TGA) that its EasyScreenTM SARS-CoV-2 Detection Kit has been approved to be listed on the ARTG in Australia.

Podcast: How UiPath's Robotic Process Automation (RPA) is helping healthcare workers

Finfeed Archived May 05, 2020

UiPath was recently recognised as the top company on The Deloitte Technology Fast 500 for 2019 and is currently helping healthcare organisations manage their operations by giving them free access to Robotic Process Automation (RPA) tools.

Covid 19